These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 38059453)

  • 21. Comparison of circulating miR-148a and miR-126 with autoantibodies as biomarkers of lupus nephritis in patients with SLE.
    Omidi F; Khoshmirsafa M; Kianmehr N; Faraji F; Delbandi A; Seif F; Shekarabi M
    J Immunoassay Immunochem; 2022 Nov; 43(6):634-647. PubMed ID: 35938736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antinucleosome antibodies as a potential biomarker for the evaluation of renal pathological activity in patients with proliferative lupus nephritis.
    Hung WT; Chen YM; Lan JL; Chen HH; Chen YH; Chen DY; Hsieh CW; Wen MC
    Lupus; 2011 Nov; 20(13):1404-10. PubMed ID: 21946514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunoglobulin E and systemic lupus erythematosus.
    Atta AM; Sousa CP; Carvalho EM; Sousa-Atta ML
    Braz J Med Biol Res; 2004 Oct; 37(10):1497-501. PubMed ID: 15448870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-titer antichromatin antibody is associated with proliferative class IV of lupus nephritis.
    Carvalho JF; Viana VS; Borba EF; do Nascimento AP; Leon EP; Testagrossa LA; Barros RT; Bonfá E
    Clin Rheumatol; 2008 Nov; 27(11):1417-21. PubMed ID: 18523820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and laboratory characteristics of early-onset and delayed-onset lupus nephritis patients: A single-center retrospective study.
    Kosałka-Węgiel J; Dziedzic R; Siwiec-Koźlik A; Spałkowska M; Milewski M; Żuk-Kuwik J; Zaręba L; Bazan-Socha S; Korkosz M
    Rheumatol Int; 2024 Jul; 44(7):1283-1294. PubMed ID: 38546745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Co-Positivity for Anti-dsDNA, -Nucleosome and -Histone Antibodies in Lupus Nephritis Is Indicative of High Serum Levels and Severe Nephropathy.
    Yang J; Xu Z; Sui M; Han J; Sun L; Jia X; Zhang H; Han C; Jin X; Gao F; Liu Y; Li Y; Cao J; Ling H; Zhang F; Ren H
    PLoS One; 2015; 10(10):e0140441. PubMed ID: 26465327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autoantibody cluster analysis in juvenile lupus nephritis.
    Sherman MA; Gunawardana A; Amirault JP; Moudgil A; Bost JE; Sule S; Srinivasalu H
    Clin Rheumatol; 2022 Aug; 41(8):2375-2381. PubMed ID: 35347489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-dsDNA antibody isotypes in systemic lupus erythematosus: IgA in addition to IgG anti-dsDNA help to identify glomerulonephritis and active disease.
    Villalta D; Bizzaro N; Bassi N; Zen M; Gatto M; Ghirardello A; Iaccarino L; Punzi L; Doria A
    PLoS One; 2013; 8(8):e71458. PubMed ID: 23951169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum levels of autoantibodies against C-reactive protein correlate with renal disease activity and response to therapy in lupus nephritis.
    Sjöwall C; Zickert A; Skogh T; Wetterö J; Gunnarsson I
    Arthritis Res Ther; 2009; 11(6):R188. PubMed ID: 20003354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IgA anti-dsDNA antibodies: A neglected serological parameter in systemic lupus erythematosus.
    Lee AYS
    Lupus; 2022 Feb; 31(2):137-142. PubMed ID: 35049409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Characteristics of serum autoantibodies in patients with lupus nephritis and tubulointerstitial damage].
    Zhang L; Chen C; Weng MT; Zheng AP; Su ML; Wang QW; Cai YM
    Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 54(6):1094-1098. PubMed ID: 36533338
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Male gender results in more severe lupus nephritis.
    de Carvalho JF; do Nascimento AP; Testagrossa LA; Barros RT; Bonfá E
    Rheumatol Int; 2010 Aug; 30(10):1311-5. PubMed ID: 19784840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Significance of Anti-Ribosomal P Protein Antibodies in Patients with Lupus Nephritis.
    Sarfaraz S; Anis S; Ahmed E; Muzaffar R
    Rev Recent Clin Trials; 2018; 13(4):281-286. PubMed ID: 29629666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simultaneous positivity for anti-DNA, anti-nucleosome and anti-histone antibodies is a marker for more severe lupus nephritis.
    Sui M; Lin Q; Xu Z; Han X; Xie R; Jia X; Guo X; Zhang W; Guan X; Ren H
    J Clin Immunol; 2013 Feb; 33(2):378-87. PubMed ID: 23100145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin.
    Wang H; Li T; Chen S; Gu Y; Ye S
    Arthritis Rheumatol; 2015 Dec; 67(12):3190-200. PubMed ID: 26245802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two-Parametric Immunological Score Development for Assessing Renal Involvement and Disease Activity in Systemic Lupus Erythematosus.
    Sjöwall C; Bentow C; Aure MA; Mahler M
    J Immunol Res; 2018; 2018():1294680. PubMed ID: 30246032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel Autoantigens Associated with Lupus Nephritis.
    Onishi S; Adnan E; Ishizaki J; Miyazaki T; Tanaka Y; Matsumoto T; Suemori K; Shudou M; Okura T; Takeda H; Sawasaki T; Yasukawa M; Hasegawa H
    PLoS One; 2015; 10(6):e0126564. PubMed ID: 26098692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BioPlex 2200 multiplexed system: simultaneous detection of anti-dsDNA and anti-chromatin antibodies in patients with systemic lupus erythematosus.
    Bardin N; Desplat-Jego S; Daniel L; Jourde Chiche N; Sanmarco M
    Autoimmunity; 2009 Jan; 42(1):63-8. PubMed ID: 19127456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of immunity index and immunopathogenesis pattern of lupus nephritis patients.
    Gao JX; Diao HL; Liu YQ; Lv M; Dong H; Zhang XM; Wang YN
    J Biol Regul Homeost Agents; 2015; 29(1):201-6. PubMed ID: 25864759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cut-off values of immunological tests to identify patients at high risk of severe lupus nephritis.
    Gargiulo MLÁ; Khoury M; Gómez G; Grimaudo S; Suárez L; Collado MV; Sarano J
    Medicina (B Aires); 2018; 78(5):329-335. PubMed ID: 30285925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.